Haozhong Ding
7PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 27, 2021
Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein.Javad Garousi, Haozhong Ding, Emma von Witting
|Aug 27, 2021
Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model.Tianqi Xu, Anzhelika Vorobyeva, Alexey Schulga
|Jul 24, 2021
Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1.Sergey M Deyev, Tianqi Xu, Yongsheng Liu
|Apr 03, 2021
Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution.Haozhong Ding, Tianqi Xu, Jie Zhang
|Jan 05, 2021
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model.Tianqi Xu, Haozhong Ding, Anzhelika Vorobyeva
|Apr 30, 2020
HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution.Haozhong Ding, Mohamed Altai, Wen Yin
Pageof 2
Frequent Collaborators
7 joint publications
Vladimir Tolmachev
7 joint publications
Anna Orlova
6 joint publications
Tianqi Xu
6 joint publications
Torbjörn Gräslund
5 joint publications
Anzhelika Vorobyeva
2 joint publications
Javad Garousi
2 joint publications
Maryam Oroujeni
2 joint publications
Sergey M Deyev
2 joint publications
Alexey Schulga
1 joint publications
Wen Yin
